Literature DB >> 26006698

NanoBRET--A Novel BRET Platform for the Analysis of Protein-Protein Interactions.

Thomas Machleidt1, Carolyn C Woodroofe2, Marie K Schwinn1, Jacqui Méndez1, Matthew B Robers1, Kris Zimmerman1, Paul Otto1, Danette L Daniels1, Thomas A Kirkland2, Keith V Wood1.   

Abstract

Dynamic interactions between proteins comprise a key mechanism for temporal control of cellular function and thus hold promise for development of novel drug therapies. It remains technically challenging, however, to quantitatively characterize these interactions within the biologically relevant context of living cells. Although, bioluminescence resonance energy transfer (BRET) has often been used for this purpose, its general applicability has been hindered by limited sensitivity and dynamic range. We have addressed this by combining an extremely bright luciferase (Nanoluc) with a means for tagging intracellular proteins with a long-wavelength fluorophore (HaloTag). The small size (19 kDa), high emission intensity, and relatively narrow spectrum (460 nm peak intensity) make Nanoluc luciferase well suited as an energy donor. By selecting an efficient red-emitting fluorophore (635 nm peak intensity) for attachment onto the HaloTag, an overall spectral separation exceeding 175 nm was achieved. This combination of greater light intensity with improved spectral resolution results in substantially increased detection sensitivity and dynamic range over current BRET technologies. Enhanced performance is demonstrated using several established model systems, as well as the ability to image BRET in individual cells. The capabilities are further exhibited in a novel assay developed for analyzing the interactions of bromodomain proteins with chromatin in living cells.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26006698     DOI: 10.1021/acschembio.5b00143

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN: 1554-8929            Impact factor:   5.100


  113 in total

1.  Enabling systematic interrogation of protein-protein interactions in live cells with a versatile ultra-high-throughput biosensor platform.

Authors:  Xiu-Lei Mo; Yin Luo; Andrei A Ivanov; Rina Su; Jonathan J Havel; Zenggang Li; Fadlo R Khuri; Yuhong Du; Haian Fu
Journal:  J Mol Cell Biol       Date:  2015-11-16       Impact factor: 6.216

Review 2.  On the different experimental manifestations of two-state 'induced-fit' binding of drugs to their cellular targets.

Authors:  Georges Vauquelin; Isabelle Van Liefde; David C Swinney
Journal:  Br J Pharmacol       Date:  2016-03-15       Impact factor: 8.739

3.  NanoLuc-Based Methods to Measure β-Arrestin2 Recruitment to G Protein-Coupled Receptors.

Authors:  Xiaoyuan Ma; Rob Leurs; Henry F Vischer
Journal:  Methods Mol Biol       Date:  2021

4.  Muscarinic receptors promote pacemaker fate at the expense of secondary conduction system tissue in zebrafish.

Authors:  Martina S Burczyk; Martin D Burkhalter; Teresa Casar Tena; Laurel A Grisanti; Michael Kauk; Sabrina Matysik; Cornelia Donow; Monika Kustermann; Melanie Rothe; Yinghong Cui; Farah Raad; Svenja Laue; Allessandra Moretti; Wolfram-H Zimmermann; Jürgen Wess; Michael Kühl; Carsten Hoffmann; Douglas G Tilley; Melanie Philipp
Journal:  JCI Insight       Date:  2019-10-17

5.  Method for Detecting Emission Spectral Change of Bioluminescent Ratiometric Indicators by a Smartphone.

Authors:  Mitsuru Hattori; Tomoki Matsuda; Takeharu Nagai
Journal:  Methods Mol Biol       Date:  2021

Review 6.  Link between a high k on for drug binding and a fast clinical action: to be or not to be?

Authors:  Georges Vauquelin
Journal:  Medchemcomm       Date:  2018-08-16       Impact factor: 3.597

7.  A dynamic and screening-compatible nanoluciferase-based complementation assay enables profiling of individual GPCR-G protein interactions.

Authors:  Céline Laschet; Nadine Dupuis; Julien Hanson
Journal:  J Biol Chem       Date:  2018-12-28       Impact factor: 5.157

8.  Synthesis and Evaluation of the First Fluorescent Antagonists of the Human P2Y2 Receptor Based on AR-C118925.

Authors:  Sean Conroy; Nicholas D Kindon; Jacqueline Glenn; Leigh A Stoddart; Richard J Lewis; Stephen J Hill; Barrie Kellam; Michael J Stocks
Journal:  J Med Chem       Date:  2018-03-28       Impact factor: 7.446

9.  Fragment-Based Discovery of a Selective and Cell-Active Benzodiazepinone CBP/EP300 Bromodomain Inhibitor (CPI-637).

Authors:  Alexander M Taylor; Alexandre Côté; Michael C Hewitt; Richard Pastor; Yves Leblanc; Christopher G Nasveschuk; F Anthony Romero; Terry D Crawford; Nico Cantone; Hariharan Jayaram; Jeremy Setser; Jeremy Murray; Maureen H Beresini; Gladys de Leon Boenig; Zhongguo Chen; Andrew R Conery; Richard T Cummings; Leslie A Dakin; E Megan Flynn; Oscar W Huang; Susan Kaufman; Patricia J Keller; James R Kiefer; Tommy Lai; Yingjie Li; Jiangpeng Liao; Wenfeng Liu; Henry Lu; Eneida Pardo; Vickie Tsui; Jian Wang; Yongyun Wang; Zhaowu Xu; Fen Yan; Dong Yu; Laura Zawadzke; Xiaoqin Zhu; Xiaoyu Zhu; Robert J Sims; Andrea G Cochran; Steve Bellon; James E Audia; Steven Magnuson; Brian K Albrecht
Journal:  ACS Med Chem Lett       Date:  2016-03-15       Impact factor: 4.345

10.  Self-Assembling NanoLuc Luciferase Fragments as Probes for Protein Aggregation in Living Cells.

Authors:  Jia Zhao; Travis J Nelson; Quyen Vu; Tiffany Truong; Cliff I Stains
Journal:  ACS Chem Biol       Date:  2015-11-06       Impact factor: 5.100

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.